Torquay

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This trial is looking at adding oleclumab or monalizumab to durvalumab for non small cell lung cancer.

This trial is looking at biomarkers to see if more people could benefit from cetuximab and panitumumab.

This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.

This trial is using pembrolizumab and rituximab for Waldenstrom’s macroglobulinaemia when it has come back after treatment or treatment has stopped working.

This trial is looking at giving acalabrutinib with chemotherapy for Diffuse Large B Cell Lymphoma (DLBCL).

This trial is looking at adding a drug called pembrolizumab to chemotherapy and radiotherapy (chemoradiotherapy) for people with invasive bladder cancer.

This study is to understand the changes that happen in the cells of people who are diagnose with cancer of unknown primary.

This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough.

This trial is for men with prostate cancer that has spread and is getting worse despite having hormone therapy or having their testicles removed.